Research Project
Grant-in-Aid for Challenging Exploratory Research
Drug-induced immune diseases, such as interstitial pneumonia caused by the anticancer drug Gefitinib, are considered to be fatal and severe side effects and important problems, which must be solved in the field of pharmaceutical health science. However, the actual cause of the diseases is not yet well understood. Inflammasomes, intracellular receptors recognizing pathogens and foreign materials, induce inflammation and cell death and have recently been shown to be the cause of various immune diseases. In this study, we revealed that several drugs activate inflammasomes composed of NLRP family molecules, and that drug-induced immune diseases may be partially caused by abnormal promotion of immune response through the activation of inflammasomes.
All 2018 2017 2016 Other
All Journal Article (9 results) (of which Int'l Joint Research: 1 results, Peer Reviewed: 7 results, Open Access: 5 results, Acknowledgement Compliant: 5 results) Presentation (18 results) (of which Int'l Joint Research: 3 results, Invited: 4 results) Book (1 results) Remarks (1 results)
実験医学 増刊「レドックス疾患学」
Volume: 36 Pages: 692-698
Cell Rep.
Volume: 21 Issue: 9 Pages: 2447-2457
10.1016/j.celrep.2017.11.007
J. Biol. Chem.
Volume: 印刷中 Issue: 20 Pages: 8174-8185
10.1074/jbc.m116.771519
Arch. Toxicol.
Volume: 印刷中 Issue: 6 Pages: 2365-2374
10.1007/s00204-016-1888-3
Adv. Biol. Regul.
Volume: 66 Pages: 46-53
10.1016/j.jbior.2017.10.007
Int. J. Mol. Sci.
Volume: 18 Issue: 1 Pages: 205-205
10.3390/ijms18010205
Arch. Biochem. Biophys.
Volume: 617 Pages: 101-105
10.1016/j.abb.2016.09.011
Volume: 17 Issue: 11 Pages: 1869-1869
10.3390/ijms17111869
日本応用酵素協会誌
Volume: 51 Pages: 7-15
http://www.pharm.tohoku.ac.jp/~eisei/eisei.HP/index.html